# Amber Implants

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amber-implants

- Industry: Medical Devices & Equipment
- Headquarters: The Hague, Netherlands
- Website: www.amberimplants.com
- Total disclosed funding: $10M
- Latest round: Series A (Jun 1, 2021)
- Investors on record: 1

## About

Based in The Hague, Netherlands, and founded in 2018 by current CEO Dr. Banafsheh Sajadi and CFO Dr. Mohammed Ahmadi, Amber Implants BV is a med-tech company developing a spinal implant specifically for vertebral fractures. The product was patented in 2019, feasibility studies continued throughout 2020, and was validated in 2021. In 2021, Amber Implants BV received USD 10 million in Series A funding co-led by returning investor Blue Sparrow and the company’s founders, with participation from other existing and individual investors. The company, as of 2022, consists of 10 employees.

The company’s team of doctors, engineers, and scientists work to help elderly clients with vertebral fractures including vertebral compression fractures and burst fractures through the development of their product, the VCFix Spinal System. The VCFix is a vertebral body augmentation system meant to improve pain control and stabilize the spine in patients. 

The company’s main product, the VCFix, consists of a preparation, implantation, and an optional supplementary fixation kit. The stand-alone implant treats and reduces compression fractures in vertebrae that have collapsed due to trauma, tumors, or degenerative diseases.

Amber Implants plans to use the funding from Blue Sparrow to advance its vertebral body augmentation system.

## Funding rounds

- Series A, Jun 1, 2021, $10M — Blue Sparrows MedTech Fund
- Seed, May 18, 2018 — Blue Sparrows MedTech Fund

## Investors

- Blue Sparrows MedTech Fund (https://capitalatlas.ai/funds/blue-sparrows-medtech-fund) — Seed, Series A